Journal article
S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension
Respirology (Carlton, Vic.), Vol.23(8), pp.771-779
08/2018
DOI: 10.1111/resp.13302
PMCID: PMC6047907
PMID: 29611244
Abstract
Molecular biomarkers are needed to refine prognostication and phenotyping of pulmonary hypertension (PH) patients. S100A12 is an emerging biomarker of various inflammatory diseases. This study aims to determine the prognostic value of S100A12 in PH.
Exploratory microarray analysis performed on peripheral blood mononuclear cells (PBMC) collected from idiopathic pulmonary fibrosis (IPF) patients suggested an association between S100A12 and both PH and mortality. So the current study was designed to evaluate for an association between S100A12 in peripheral blood collected from two well-phenotyped PH cohorts in two other centres to derive and validate an association between S100A12 protein serum concentrations and mortality.
The majority of the patients in the discovery and validation cohorts were either World Health Organization (WHO) group 1 (pulmonary arterial hypertension (PAH)) or 3 (lung disease-associated) PH. In the discovery PH cohort, S100A12 was significantly increased in patients with PH (n = 51) compared to controls (n = 22) (29.8 vs 15.7 ng/mL, P < 0.001) and negatively correlated with cardiac output (r = -0.58, P < 0.001) in PH patients. When S100A12 data were pooled from both cohorts, PAH and non-PAH PH patients had higher S100A12 compared to healthy external controls (32.6, 30.9, 15.7 ng/mL; P < 0.001). S100A12 was associated with an increased risk in overall mortality in PH patients in both the discovery (n = 51; P = 0.008) and validation (n = 40; P < 0.001) cohorts.
S100A12 levels are increased in PH patients and are associated with increased mortality.
Details
- Title: Subtitle
- S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension
- Creators
- Argyrios Tzouvelekis - Yale UniversityJose D Herazo-Maya - Yale UniversityChangwan Ryu - Yale UniversityJen-Hwa Chu - Yale UniversityYingze Zhang - University of PittsburghKevin F Gibson - University of PittsburghPercy K Adonteng-Boateng - Yale UniversityQin Li - Yale UniversityHongyi Pan - Yale UniversityBenjamin Cherry - Yale UniversityFerhaan Ahmad - University of IowaHubert J Ford - University of North Carolina at Chapel HillErica L Herzog - Yale UniversityNaftali Kaminski - Yale UniversityWassim H Fares - Yale University
- Resource Type
- Journal article
- Publication Details
- Respirology (Carlton, Vic.), Vol.23(8), pp.771-779
- DOI
- 10.1111/resp.13302
- PMID
- 29611244
- PMCID
- PMC6047907
- NLM abbreviation
- Respirology
- ISSN
- 1323-7799
- eISSN
- 1440-1843
- Grant note
- R00 HL114651 / NHLBI NIH HHS R01 HL127349 / NHLBI NIH HHS U01 HL108642 / NHLBI NIH HHS R01 HL109233 / NHLBI NIH HHS UL1 RR024153 / NCRR NIH HHS R03 HL095401 / NHLBI NIH HHS UL1 TR001863 / NCATS NIH HHS
- Language
- English
- Date published
- 08/2018
- Academic Unit
- Radiology; Molecular Physiology and Biophysics; Cardiovascular Medicine; Fraternal Order of Eagles Diabetes Research Center; Internal Medicine
- Record Identifier
- 9984297493702771
Metrics
49 Record Views